Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis

NCT01169844 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis

Interventions

BIOLOGICAL: AIN457A
OTHER: Other

Sponsor

Novartis Pharmaceuticals